<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Pharmaceutical and Biotech Manufacturing Data Integrity</title><link>/industries/lifesciences/b/life-sciences-blog/posts/pharmaceutical-and-biotech-manufacturing-data-integrity</link><description>The integrity of the data behind the production of pharmaceutical products is paramount. In recent years, the U.S. Food &amp;amp; Drug Administration (FDA) has increasingly observed data integrity related Current Good Manufacturing Practices (CGMP) violations</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>